UPS (NYSE: UPS) is expanding its specialty pharmaceuticalofferings by establishing UPS Cold Chain Solutions, a comprehensivesuite of cold chain technologies, best-in-class capabilities, andnew and expanded global facilities providing complete, end-to-endtemperature-controlled logistics.
“Our customers have been taking advantage of our cold chaincapabilities for years, but the pandemic caused UPS to move evenfaster to enhance an integrated set of cold chain solutions tosupport the future of the pharmaceutical and medical deviceindustry,” said Wes Wheeler, UPS Healthcare president. “UPS’snear-perfect, on-time delivery of the COVID-19 vaccine proves howeffectively and efficiently our network handles biologicallyderived drugs, even at extreme temperatures.”
Chronic and life-threatening diseases, including cancers,respiratory, autoimmune and cardiovascular conditions, are thefastest growing disease categories in the world, creating a rapidacceleration in the development of biologically derived,temperature-controlled drugs and therapies. According to theBiopharma Cold Chain Sourcebook, cold chain trends show 48 percentgrowth between 2018 and 2024 for drugs that require at least 2 to 8degrees Celsius storage and shipping. Additionally, the overallmarket for cold chain services (packaging, transportation and dataservices) is expected to significantly accelerate growth over thenext three years, growing by 24 percent by 2024, after posting a 10percent increase from 2019 to 2020.
“The future of the healthcare and specialty pharmaceuticalindustries will increasingly rely on robust cold chain networks tosafely deliver temperature-controlled drugs and therapies tocustomers,” said Kate Gutmann, UPS chief sales and solutionsofficer and SVP, UPS Global Healthcare. “The continued evolution ofour cold chain offerings ensures UPS is ready for the future andcan continue to provide long-term value for our healthcarecustomers.”
Managing temperature excursion end-to-end
UPS Cold Chain Solutions is purpose-built to providepharmaceutical companies, healthcare providers and laboratories afull, end-to-end cold chain service offering, including storage anddistribution, transportation, visibility, and quality assurancecapabilities to meet their complex demands for critical productsaround the world.
As part of a continued, aggressive strategy to buildsophisticated capabilities in cold chain logistics, UPS Healthcareis expanding and augmenting its temperature-controlled products andservices, including:
